Skip to content

Frontlight ResearchEarly access

Trial site

Toronto Digestive Disease Associates Inc

Toronto, Ontario M3N 2V7, CanadaNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Crohn's disease
Ulcerative colitis

Closed trials

Completed
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
NCT03283085· Phase 3· Shire· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Toronto Digestive Disease Associates Inc: trial site – Frontlight Research